Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hayden Locke, CEO Emmerson plc, a low cost high margin potash investment
Richard Slape, Oil consultant - Avoiding Losers and Picking Winners, his personal strategy




Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,555.00Bid: 1,556.80Ask: 1,557.20Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,555.00High: 0.00Low: 0.00Yesterday’s Close: 1,555.00

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1555.00
Share Price SpacerBid
1556.80
Share Price SpacerAsk
1557.20
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
1,555.00
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
1,555.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,919.00m £76,490.45m 1,500

52 Week High 1,648.80 52 Week High Date 3-DEC-2018
52 Week Low 1,281.60 52 Week Low Date 26-MAR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 21.099 73.70 80.00 5.14


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Lloyds, BP, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Aviva

Users who hold GSK also hold: Vodafone, BP, Lloyds, National Grid, Royal Dutch Shell B, HSBC, Tesco, Aviva, Centrica, BT


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Mar-19
18:45:01
1,555.637
2,603
Sell* 
1,556.80
1,557.20
40.49k
Trade Type:
Ordinary

22-Mar-19
17:12:14
1,555.00
163,800
Sell* 
1,556.80
1,557.20
2.547M
Trade Type:
Ordinary
Delayed publication

22-Mar-19
17:12:14
1,555.00
78,903
Sell* 
1,556.80
1,557.20
1.227M
Trade Type:
Ordinary
Delayed publication




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-Mar-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
08364818
11-Mar-19Buy
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1527.59GBX8364826
11-Mar-19Buy
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1527.59GBX819983865
View more Glaxosmithkline directors dealings >>


Becomingpoor
Posts: 370
Opinion:No Opinion
Price:1,555.00
RE: Divedend Reinvestment
Today 06:51
Hargreaves invest divi money between 11th and 18th of the following month. Therefore if Gsk pay divi on 4th April it will get invested between 11th and 18th.

Sometimes a bit annoying because if the divi is paid on 15th for example HL will wait to following month but you can always turn to cash and do it yourself although charges higher
driftking27
Posts: 1,442
Opinion:Buy
Price:1,567.40
RE: Divedend Reinvestment
Fri 11:38
turfmoor
Posts: 53
Opinion:No Opinion
Price:1,566.60
RE: Divedend Reinvestment
Fri 09:45
Thanks for that.
LordAdam
Posts: 626
Opinion:No Opinion
Price:1,565.20
RE: Divedend Reinvestment
Fri 09:38
It's when they get around to it ... although it will never be earlier than the payment date. Usually they lump all the reinvestments together and do a bulk purchase in the market as soon as is reasonably possible after the money comes through. The reason behind that is that they are then not liable for making a discretionary decision about timing which might go against you leading to a claim that they acted incorrectly. If you are lucky they then split the costs across everyone and you get an advantage in terms of trading costs. However, the market makers know what is going to happen and could manipulate the price on payment day or stock pile stock ready for it.

Mike
turfmoor
Posts: 53
Opinion:No Opinion
Price:1,566.00
Divedend Reinvestment
Fri 07:35
Taken this option with GSK via HL.. I still dont understand on which date the shares are purchased. Is it x date, payment date or whenever they get round to it!
View more share chat for Glaxosmithkline (GSK) >>




Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.